By 2028, the market size of dermal fillers will exceed USD 9.421.3 billion

New York, October 6, 2021 (GLOBE NEWSWIRE) – Dermal fillers market: key insights based on our “Dermal fillers market by 2028-global analysis and forecast-by product, material, application, end user and The new study of geographic division”,” the dermal filler market size is expected to increase from US$4.39198 billion in 2021 to US$9.4213.3 billion in 2028; it is estimated that from 2021 to 2028, the compound annual growth rate is 11.5%.
Dermal fillers market: competitive landscape and key developments AbbVie, Galderma, Merz Pharma, Suneva Medical, BIOXIS Pharmaceuticals, HUADONG MEDICINE CO.,LTD, BIOPLUS CO., LTD., TEOXANE LABORATORIES, BIOHA LABORATORIES and Prollenium Medical are the key points A company operating in the dermal filler market. Leading companies focus on expanding and diversifying their market share and acquiring new customer bases to tap existing business opportunities.
In February 2021, Galderma announced that the FDA approved Restylane Defyne for the enhancement and correction of mild to moderate chin retraction in adults 21 years of age and older.
In February 2021, Merz Aesthetics, the world’s largest professional medical beauty company, announced the launch of BELOTERO BALANCE (+) in the United States, which is a lidocaine preparation of BELOTERO BALANCE.
Get an exclusive sample page of the dermal filler market size at impact and strategic insight global analysis
In June 2020, Galderma launched a lip filler with home-photographed models and telemedicine materials. For example, it switched to digital information and materials for healthcare providers to use with patients during telemedicine meetings.
In 2020, North America dominates the dermal filler market, and the United States is the largest shareholder in the regional market. In addition, the Asia-Pacific region is expected to achieve the highest compound annual growth rate in the market from 2021 to 2028. The growth of the North American market is attributed to the high adoption of non-surgical procedures and mature medical infrastructure. High disposable income and excellent spending power, coupled with willingness to spend money on cosmetic surgery, have further promoted the adoption of dermal fillers in the region. The average life expectancy in the United States is increasing, which has also led to an increase in the use of dermal fillers. According to Our World in Data, in 2019, the United Nations estimated that the global average life expectancy was 72.6 years; today’s global average is higher than any country in the 1950s. In addition, according to forecasts by the World Health Organization, the number of people over 65 in the United States is expected to increase from 52 million in 2018 to 95 million in 2060, and the proportion of this age group in the total population will rise from 16% to 2018- During 2060 it is 23%.
The strategic activities of dermal fillers market participants have contributed to market growth: dermal fillers market participants are focused on introducing innovative products through a wide range of strategic activities. Compared with existing products on the market, these devices may produce better therapeutic effects. Galderma announced that the US Food and Drug Administration (FDA) has approved Restylane Kysse for lip augmentation and correction of upper perioral wrinkles (wrinkles around the upper lip) in adults over 21 years of age. Restylane Kysse is the first hyaluronic acid (HA) filler to use XpresHAN technology (pronounced ex-ˈspre-shan) specifically for lips. Restylane Kysse has been proven to last up to 1 year and has achieved high patient satisfaction among the treated population. Restylane HA dermal filler series has undergone more than 40 million treatments worldwide and is still increasing. It is the most extensive dermal filler product portfolio.
Download the sample PDF brochure of the dermal filler market size and growth research report at
Allergan Aesthetics, a company of AbbVie, announced an agreement with Luminera, a privately-owned beauty company based in Israel that owns a series of dermal filler products and pipelines. According to the terms of the agreement, Allergan Aesthetics will acquire Luminaria’s complete dermal filler product portfolio and R&D pipeline, and further enhance Allergan Aesthetics’ leading dermal filler product portfolio through its JUVÉDERM filler series. In addition, in 2018, the company also launched a new JUVÉDERM advertising campaign to empower the next generation of consumers “JUVÉDERM IT”. It aims to further the goal of Allergan, which is to make the JUVÉDERM filler series the first choice of consumers and a well-known brand.
Merz announced the launch of Belotero Lips, a product designed specifically for lip augmentation and wrinkle treatment. This series includes two complementary HA dermal filler products. Therefore, during the forecast period, strategic activities and product innovation are expected to provide growth momentum for the dermal filler market.
Dermal filler market: segmentation overview The dermal filler market has been segmented according to products, materials, applications, and end users. By product, the dermal filler market is divided into biodegradable and non-biodegradable. The biodegradable market segment is expected to occupy a larger market share in 2021, and is expected to record a higher compound annual growth rate during the forecast period. According to materials, the dermal filler market has been subdivided into calcium hydroxyapatite, hyaluronic acid, collagen, poly-l-lactic acid, polymethyl methacrylate (PMMA), fat and other materials. It is estimated that by 2021, the hyaluronic acid segment will occupy the largest market share, and the collagen segment is expected to have the highest compound annual growth rate during the forecast period. According to the application, the dermal filler market has been subdivided into facial line correction treatment, lip augmentation, plastic surgery, scar treatment, etc. The facial line correction treatment segment is expected to occupy the largest market share in 2021, while the cosmetic surgery segment is expected to have the highest compound annual growth rate during the forecast period. According to end users, the dermal filler market has been subdivided into dermatology clinics, multi-specialty hospitals, and outpatient surgery centers. The dermatology clinic sector may occupy the largest market share in 2021. On the other hand, the multi-specialty hospital sector is expected to have the highest compound annual growth rate during the forecast period.
Order a copy of the 2021-2028 dermal filler market size, share, strategic insight and forecast research report on
Due to the COVID-19 pandemic, major markets for dermal fillers such as the United States, China, Spain, Italy, Germany, France, and the United Kingdom are suffering huge economic losses. Many companies lay off employees to maintain business, which has triggered high unemployment rates and reduced people’s purchasing power. Therefore, due to personal and economic losses, people become more picky about cosmetic and cosmetic surgery. This is expected to limit market growth during the forecast period. In addition, various cosmetics facilities and clinics have been closed for more than 3 months and suffered a significant loss of income. According to a report released by Hamilton Fraser, with the help of the British National Health Service (NHS), more than 80% of UK clinics were closed during the lockdown period, resulting in an 86% reduction in income. In addition, the American Association of Plastic Surgeons recommends that all practitioners stop providing customers with any optional or non-essential services to reduce the risk of SARS-CoV-2 virus transmission. As a result, the continued increase in the prevalence of COVID-19 has led to a reduction in the number of cosmetic procedures performed in the past few quarters, thereby reducing the demand for dermal fillers.
However, despite these adverse effects, Galderma is still preparing to launch its newly approved Restylane Kysse lip filler. In addition, like many businesses across the UK, cosmetic clinics reopened last week and resumed providing treatments such as dermal fillers and botulinum. Despite the lockdown in the UK, there are still several clinics that are allowed to perform filling procedures for medical purposes, such as treating acne and scars.
Browse related reports: Anti-aging drug market forecast in 2028-impact and global analysis of COVID-19 by drug category (serum and supplements, antioxidants and enzymes, stem cells, other drugs); applications (skin care, hair care, age-related Disease, others); distribution channels (retail pharmacies, online pharmacies, other) and geographic
Anti-aging cosmetics market forecast in 2028-COVID-19 impact and global product type analysis (skin care, hair care, cosmetics, eye care, others); form (cream, lotion, serum, other); end user (male, female) ); distribution channels (supermarkets/hypermarkets, cosmetics stores, online stores, other)
Anti-aging market forecast in 2028-Covid-19 impact and global analysis-by product (UV absorbers, anti-wrinkle products, dermal fillers, botulinum, anti-stretch mark products); equipment (anti-cellulite treatment, laser beauty equipment) , Micro-crystal peeling equipment, radio frequency equipment, etc.); end users (hospitals, clinics, home health care)
Facial Fat Transplant Market Forecast to 2028-Global analysis of COVID-19 impact and target areas (nasolabial folds, lips, puppet folds, temples, chin, under-eye area); treatments (dermal fillers, fat injections, others) ; End users (hospitals, cosmetic surgery clinics, other) and geographic
Facial syringe market forecast in 2028-Covid-19 impact and global analysis-by type (dermal fillers or injectable implants, anti-aging or anti-wrinkle injections); application (facial line correction treatment, face lifting, lip treatment); End users (dermatology clinics and beauty centers, hospitals, other) and geography
Facial Beauty Market Forecast to 2028-Covid-19 Impact and Global Analysis-By Product Type (Botulinum Toxin and Dermal Fillers); End User (Beauty Clinic, Beauty Salon and Hospital) and Geography
Biodegradable injectable dermal filler market forecast by 2028-COVID-19 impact and global type analysis (biodegradable, non-biodegradable); end users (specialty and dermatology clinics, hospitals and clinics, others) and geography
Facial beauty product market forecast to 2028-COVID-19 impact and global product analysis (botulinum toxin, dermal fillers, granules and polymer fillers, etc.); end users (beauty clinics, hospitals, beauty salons) and geography
2028 Injectable Dermal Filler Market Forecast-COVID-19 Impact and Global Type Analysis (Biodegradable, Non-biodegradable); End User (Specialty and Dermatology Clinics, Hospitals and Clinics, Others) and Geography
2028 Injectable facial beauty product market forecast-COVID-19 impact and global product analysis (botulinum toxin, dermal fillers, granular and polymer fillers, etc.); end users (beauty clinics, hospitals, beauty salons) and geography
Hyaluronic acid market forecast to 2028-Covid-19 impact and global analysis-by product type (five injection cycles, three injection cycles, single injection cycle); applications (dermal fillers, osteoarthritis, ophthalmology, bladder Ureteral reflux) and geography
Hyaluronic acid product market forecast to 2028-COVID-19 impact and global product analysis (single-cycle injection products, three-cycle injection products, five-cycle injection products); applications (osteoarthritis, ophthalmology, dermal fillers, vesicoureter Reflux); end users (hospitals, clinics, homes); distribution channels (hospital pharmacies, retail pharmacies, pharmacies)
About us: Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients obtain solutions that meet their research needs through our joint and consulting research services. We focus on industries such as semiconductors and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical equipment, technology, media and telecommunications, chemicals and materials.
Contact us: If you have any questions about this report or want more information, please contact us:
Contact: Sameer Joshi Email: Tel: +1-646-491-9876 Press release-
Contact us: LinkedIn: https: // |

Post time: Nov-26-2021